[admin]

Levaquin (levofloxacin) oral solution 25 mg/mL is indicated for the treatment of acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, nosocomial pneumonia, community-acquired pneumonia, complicated and uncomplicated skin infections, chronic bacterial prostatitis, complicated and uncomplicated urinary tract infections, and acute pyelonephritis.
Related Results
Levaquin approvalLevaquin doseNew indication for LevaquinLevaquin tablets and oral solutionShort-course Levaquin approved

[admin]

Ear, Nose & Throat Journal - The prevalence of colonization with drug-resistant pneumococci among adult workers in children’s daycare


The article “Medications for Migraine Prophylaxis” (January 1, 2006, page 72) contained an error in the section titled “Pregnancy” on page 77. The second sentence of this section incorrectly listed fluoxetine (Prozac) as a U.S. Food and Drug Administration (FDA) pregnancy category B drug, and that it could be considered for preventive therapy of chronic migraine in women who are pregnant. In March 1997, the FDA reclassified fluoxetine as a pregnancy category C drug, and it should be used with the same caution as all pregnancy category C drugs in women who are pregnant. The online version of this article has been corrected.
Most Popular
Five Ways To Successfully Negotiate A Salary
Eight Major Job Trends For 2008
Today’s Best Part-Time Jobs
3 Questions No Job Seeker Ever Wants To Be Asked?
10 Jobs That Pay $30 An Hour
The Point-of-Care Guides “Treating Adult Women with Suspected UTI” (January 15, 2006, page 293) contained an error in the patient encounter form on page 295. Under the Treatment Plan section, the dosage for levofloxacin (Levaquin) was incorrectly listed as 500 mg twice per day. The correct dosage is 250 mg once daily. The corrected encounter form is reprinted on page 1686 of this issue, and the online version of this article has been corrected.
COPYRIGHT 2006 American Academy of Family Physicians
COPYRIGHT 2008 Gale, Cengage Learning

[admin]

LegalView Informs Mesothelioma Blog Readers with Details on Asbestos: Silent Killer of American Vete

Denver, CO - LegalView, the most comprehensive legal resource available on the Internet, unveiled details of a “silent killer” of American veterans that dates back to World War II. Asbestos fibers and dust may have been silently killing veterans returning home from American-fought wars, and has long been overlooked, according to veteran and book author William S. Burton Sr. Currently, many scientists and researchers have deemed traumatic brain injury (TBI) to be the “signature injury” of the recent war, but veterans also suffer from mesothelioma cancer caused by the inhalation of asbestos.
According to Burton, veterans, especially navy veterans from World War II, have had difficulties proving their asbestos-induced conditions to the Department of Veterans Affairs (VA). Veterans as well as those suffering from the cancer are encouraged to locate a mesothelioma law firm that can provide a plethora of experienced mesothelioma attorneys to choose from.
Mesothelioma cancer is caused by inhaling asbestos fibers, which were mined throughout the world in the 20th century. Tremolite, which is found in asbestos, caused fibers being inhaled to line the inside of the lung causing the deadly form of cancer that can spread to other parts of the body. While much is being done to find out about mesothelioma treatment, there are no known cures and very few treatments that can offer an increased survival rate. Veterans who suffer from this lung condition should seek medical attention and consult a mesothelioma attorney to learn about receiving medical disability and compensation claims for war-related conditions/illnesses.
For more on mesothelioma cancer visit LegalView’s homepage. On this site, find several other various categories to navigate through and locate information on legal topics such as the faulty Zimmer Durom cup or the tendonitis-inducing Levaquin. Also learn the latest on the Viapro recall.
The failing Durom cup hip socket from Zimmer Holdings has stopped being manufactured while hundreds of physicians claim the Durom cup risks have caused failing hip components among some patients, which would likely be cause for an additional hip replacement surgery. The faulty hip socket has already been implanted into approximately 12,000 patients since the components release in 2006.
Levaquin, which is an antibiotic belonging to the fluoroquinolones drug group, was recently issued the harshest label possible by the U.S. Food and Drug Administration (FDA). The black box label is a warning for physicians that the drug includes serious side effects such as the increased risk of tendonitis or tendon rupture among patients. Individuals taking Levaquin are encouraged to contact a pharmaceutical attorney to learn about the details of a Levaquin class action lawsuit.
The ongoing complications associated with Viapro were discovered after an internal investigation and test by the FDA that found an undeclared ingredient in the drug. Viapro, which treats erectile dysfunction (ED) and sexual impotency, has been recalled, but patients may still suffer from the Viapro side effects. Those who are at risk are those also consuming medications containing nitrates, which can be found in high blood pressure, high cholesterol, heart disease and diabetes medications.
About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation’s most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com’s superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at LegalView.com.

[admin]

Adverse Event Reporting News - Levaquin tablets and oral solution

Levaquin (levofloxacin) Injection, for Intravenous Use
Levaquin (levofloxacin in 5% dextrose) Injection, for Intravenous Use
WARNINGS AND PRECAUTIONS
Photosensitivity/Phototoxicity
Moderate to severe photosensitivity/phototoxicity reactions, the latter of which may manifest as exaggerated sunburn reactions (e.g., burning, erythema, exudation, vesicles, blistering, edema) involving areas exposed to light (typically the face, “V” area of the neck, extensor surfaces of the forearms, dorsa of the hands), can be associated with the use of quinolones after sun or UV light exposure. Therefore, excessive exposure to these sources of light should be avoided. Drug therapy should be discontinued if photosensitivity/ phototoxicity occurs [See ADVERSE REACTIONS (6.3); PATIENT COUNSELING INFORMATION (17.3)]
Related Results
Levaquin approvalLevaquin doseNew indication for LevaquinOral solution levaquin approvedShort-course Levaquin approved
ADVERSE REACTIONS
Serious and Otherwise Important Adverse Reactions
Photosensitivity/Phototoxicity
Postmarketing Experience
Table
Skin and Subcutaneous Tissue Disorders–Photosensitivity/Phototoxicity Reaction [see WARNINGS and PRECAUTIONS (5.10)]
PATIENT COUNSELING INFORMATION
Serious and Potentially Serious Adverse Reactions
Photosensitivity/Phototoxicity
What are possible side effects of Levaquin?
Sun sensitivity (photosensitivity) …
COPYRIGHT 2008 Washington Information Source, Inc.
COPYRIGHT 2008 Gale, Cengage Learning

[alena]

Levaquin is in a group of antibiotics called fluoroquinolones. It fights bacteria in the body. Levaquin is used to treat bacterial infections of the skin, sinuses, kidneys, bladder, or prostate. It is also used to treat bacterial infections that cause bronchitis or pneumonia, and to treat people who have been exposed to anthrax.Levaquin may also be used for other purposes not listed in this medication guide.

[techno]

Can it help me,if i have bacterial infections of the skin,i drunk many antibiotics,but they not help me( Who know? Please write me!I don't know what i must do,may be somebody had these problem? wait an answer